UC Irvine-led team creates first cell type-specific gene regulatory maps for Alzheimer’s disease
Newly developed data analysis method uncovers causal mechanisms of disease
2026-02-12
(Press-News.org)
NEWS
EMBARGOED UNTIL 4:00 A.M. PACIFIC TIME THURSDAY, FEB. 12, 2026
NOTE TO EDITORS: PHOTO AVAILABLE
Contact: Carly Murphy
949-501-1008
murphyco@uci.edu
Public health researchers use newly developed data analysis method to build the first cell type-specific gene regulatory maps for Alzheimer’s disease, revealing the genetic mechanisms operating within patients’ brains.
The study also identified numerous influential “hub genes” that offer promising new targets for early detection and therapeutic intervention.
The National Institute on Aging and the National Cancer Institute provided support.
Irvine, Calif. — Researchers led by Min Zhang and Dabao Zhang of the University of California, Irvine’s Joe C. Wen School of Population & Public Health have created the most detailed maps to date showing how genes causally regulate one another across different types of brain cells affected by Alzheimer’s disease.
Using their newly developed machine learning framework, SIGNET, which reveals cause-and-effect relationships rather than simple genetic correlations, they uncovered key biological pathways that may drive memory loss and brain degeneration.
The study, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, also identifies new genes that could serve as targets for future treatments. The work was funded in part by the National Institute on Aging and the National Cancer Institute.
Alzheimer’s disease, the leading cause of dementia, is projected to affect nearly 14 million Americans by 2060. Scientists have already found many genes linked to the disease, such as APOE and APP, but they still don’t fully understand how these genes disrupt healthy brain function.
“Different types of brain cells play distinct roles in Alzheimer’s disease, but how they interact at the molecular level has remained unclear,” said Min Zhang, co-corresponding author and professor of epidemiology and biostatistics. “Our work provides cell type-specific maps of gene regulation in the Alzheimer’s brain, shifting the field from observing correlations to uncovering the causal mechanisms that actively drive disease progression.”
To create these maps, team members analyzed single-cell molecular data from brain samples of 272 participants in long-term memory and aging studies in the Religious Orders Study and the Rush Memory and Aging Project. They developed SIGNET as a scalable, high-performance computing method that integrates single-cell RNA sequencing and whole-genome sequencing data and reveals cause-and-effect relationships among all genes.
The researchers identified causal gene regulatory networks for six major types of brain cells. This allowed them to determine which genes are likely controlling other genes, something traditional correlation-based tools cannot reliably do.
“Most gene-mapping tools can show which genes move together, but they can’t tell which genes are actually driving the changes,” said Dabao Zhang, co-corresponding author and professor of epidemiology and biostatistics. “Some methods also make unrealistic assumptions, such as ignoring feedback loops between genes. Our approach takes advantage of information encoded in DNA to enable the identification of true cause-and-effect relationships between genes in the brain.”
The scientists found that the most dramatic gene disruptions in Alzheimer’s disease occur in excitatory neurons – the nerve cells that send activating signals – with analyses of nearly 6,000 cause-and-effect interactions indicating that these cells undergo extensive rewiring as the disease progresses.
They also pinpointed hundreds of “hub genes” that act as major control centers, influencing many other genes and likely playing key roles in driving harmful changes. These could serve as new targets for early detection and therapeutic intervention. In addition, the team discovered new regulatory roles for well-known genes such as APP, which strongly controlled other genes in inhibitory neurons.
Importantly, the researchers confirmed these findings using an independent set of human brain samples, strengthening confidence that these gene-to-gene relationships reflect real biological mechanisms involved in Alzheimer’s disease.
SIGNET can also be used to study many other complex diseases, including cancer, autoimmune disorders and mental health conditions.
Danni Liu, Zhongli Jiang, Hyunjin Kim, Anke M. Tukker, Ashish Dalvi, Junkai Xie, Yan Li, Chongli Yuan, Aaron B. Bowman, Dabao Zhang and Min Zhang from UC Irvine contributed to the study.
Affiliations:
UC Irvine Department of Epidemiology and Biostatistics; Purdue University Department of Statistics, School of Health Sciences, and Davidson School of Chemical Engineering; UC Irvine Center for Complex Biological Systems.
About the University of California, Irvine: Founded in 1965, UC Irvine is a member of the prestigious Association of American Universities and is ranked among the nation’s top 10 public universities by U.S. News & World Report. The campus has produced five Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UC Irvine has more than 36,000 students and offers 224 degree programs. It’s located in one of the world’s safest and most economically vibrant communities and is Orange County’s second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. For more on UC Irvine, visit www.uci.edu.
Media access: Radio programs/stations may, for a fee, use an on-campus studio with a Comrex IP audio codec to interview UC Irvine faculty and experts, subject to availability and university approval. For more UC Irvine news, visit news.uci.edu. Additional resources for journalists may be found at https://news.uci.edu/media-resources.
END
ELSE PRESS RELEASES FROM THIS DATE:
2026-02-12
Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from effectively attacking tumours – and, in mice, they've found a way to neutralize it.
Led by Université de Montréal medical professor Dr. André Veillette, director of the molecular oncology research unit at the UdeM-affiliated Montreal Clinical Research Institute (IRCM), the breakthrough is detailed in a study published in Nature.
An internal brake independent of tumor cells
In their lab, Veillette and his team demonstrated that, ...
2026-02-12
Artificial intelligence is increasingly able to simulate human behavior and answer online surveys and political polls, putting the reliability of survey-based research at risk. Consequences can be serious not only for science and research - online surveys are a cornerstone of modern social-science research - but also for policy and participation of people in democratic processes, as surveys are widely used in political polls. This is a worry expressed in a comment in Nature by three researchers ...
2026-02-12
Ambitious climate action to improve global air quality could save up to 1.32 million lives per year by 2040, according to a new study.
The research, led by Cardiff University, shows how developing countries rely heavily on international cooperation to see these benefits, because much of their pollution originates outside their borders.
The first-of-its-kind study analysed these cross-border pollution “exchanges” for nearly every country – 168 in total.
Their findings, published in Nature Communications, reveal how a fragmented world, with little collaborative climate mitigation policymaking, would lead ...
2026-02-12
Kyoto, Japan -- The enzyme Na⁺-NQR is a sodium pump that drives the respiration of many marine and pathogenic bacteria. Using redox reactions, the process of exchanging electrons between materials, it powers the transportation of sodium ions across the membrane, supporting the growth of the bacteria.
Yet there is a mystery behind this mechanism, as scientists have had trouble understanding exactly how the redox reactions are linked to sodium-pumping. In particular, the lack of structural information on the key intermediate states that form while the enzyme is operating has posed a major challenge; determining these structures is essential to understanding how the ...
2026-02-12
Atrial fibrillation (AF), the most common chronic cardiac arrhythmia in clinical practice, is very challenging to treat once it becomes persistent, after which spontaneous return to normal rhythm becomes highly unlikely. A multidisciplinary study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and published in Circulation Research now provides a new perspective on why this arrhythmia can persist long-term, highlighting the key role of non-contractile cardiac cells.
AF has traditionally been viewed as a purely electrical disorder of cardiomyocytes—the heart’s contractile cells. However, the ...
2026-02-12
Ghent, 12 February 2026 – VIB and Ghent University researchers have identified and characterized a previously unknown cellular barrier in the brain, which sheds new light on how the brain is protected from the rest of the body. In a study published in Nature Neuroscience, the scientists also reveal a new pathway by which the immune system can impact the brain.
Prof. Roosmarijn Vandenbroucke (VIB–UGent Center for Inflammation Research): “These findings reveal how vulnerable and protectable the brain is, opening new perspectives for more targeted interventions in brain disorders.”
The ...
2026-02-12
In rural regions of Africa, high blood pressure often goes untreated because health centres are far away and there is a shortage of health professionals. A study in Lesotho shows that, with the help of a tablet app, villagers who have received training achieve better blood pressure control in their village community compared to normal treatment in healthcare facilities. The results provide the first robust data for an approach that could significantly improve access to blood pressure treatment in underserved regions. ...
2026-02-12
Scientists at the University of Pittsburgh School of Medicine discovered a surprising new way the body can fight insulin resistance and diabetes – by boosting a special type of “good” immune cell in fat tissue.
Announced today in Nature Communications, the preclinical findings pave the path to develop a medication to treat and prevent type 2 diabetes, potentially replacing or supplementing GLP-1 weight maintenance drugs that lose effectiveness over time.
“One-third of our population is obese or overweight – over the next decade or so, ...
2026-02-12
Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles following research by Queen Mary University of London which has led to a change to NHS treatment guidelines. For people with the condition, this means fewer toxic side effects and a better quality of life during treatment.
Until recently, people with advanced bladder cancer routinely received between four to six cycles of intensive chemotherapy, followed by avelumab, a type of immunotherapy, as standard NHS care. ...
2026-02-12
Nighttime blood pressure dipped by 3.5%, heart rate dipped by 5% compared to controls
Given high adherence rate (nearly 90%), novel approach may be a more accessible non-pharmacological strategy for improving cardiometabolic health
‘It’s not only how much and what you eat, but also when you eat relative to sleep that is important’
CHICAGO --- A new Northwestern Medicine study has personalized overnight fasting by aligning it with individuals’ circadian sleep-wake rhythm — an important regulator of cardiovascular and metabolic function — without changing their caloric ...
LAST 30 PRESS RELEASES:
[Press-News.org] UC Irvine-led team creates first cell type-specific gene regulatory maps for Alzheimer’s disease
Newly developed data analysis method uncovers causal mechanisms of disease
